Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
Journal: The American journal of gastroenterology
Published: September 25, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Journal: Hepatology (Baltimore, Md.)
Published: April 21, 2020
Survey of Women Physicians' Experience with Elected Leadership Positions.
Journal: Health equity
Published: July 11, 2019
Analysis of Gender Equity in Leadership of Physician-Focused Medical Specialty Societies, 2008-2017.
Analysis of Gender Equity in Leadership of Physician-Focused Medical Specialty Societies, 2008-2017.
Journal: JAMA internal medicine
Published: January 08, 2019
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Journal: Journal of hepatology
Published: March 29, 2018
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
Journal: Gastroenterology
Published: March 12, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
Journal: The American journal of gastroenterology
Published: September 14, 2017
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
Journal: Journal of viral hepatitis
Published: September 01, 2017
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: May 23, 2017
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
Journal: Annals of hepatology
Published: October 15, 2016
Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).
Journal: Hepatology (Baltimore, Md.)
Published: September 04, 2015
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.
Journal: Annals of internal medicine
Published: April 25, 2015
Last Updated: 09/26/2026